ProPhase Labs, Inc (NASDAQ:PRPH) CEO Ted Karkus presents at Proactive's One2One virtual investor forum.
ProPhase Labs is a diversified medical science and technology company with deep experience with OTC consumer healthcare products and dietary supplements. The company said its testing integrates the Spectrum Solutions saliva self-collection system with a new, advanced multiplex qPCR platform for the simultaneous RNA detection of not only COVID-19 but also its viral mutations, as well as Influenza A, B, and more.